Literature DB >> 16849398

Enhancing validity in co-occurring disorders treatment research.

Gregory J McHugo1, Robert E Drake, Mary F Brunette, Haiyi Xie, Susan M Essock, Alan I Green.   

Abstract

Despite the high prevalence of co-occurring mental health and substance-use disorders, there has been a relative lack of treatment research with this population, and the existing research often has limited validity. This article explores some of the barriers to the conduct of research on promising interventions for substance-abuse treatment for people with co-occurring disorders, using the concepts of external and ecological validity to make recommendations for future investigation. The central recommendation is to move rapidly from efficacy studies to more credible and valid effectiveness studies, in order to facilitate the adoption of evidence-based interventions in routine practice settings.

Entities:  

Mesh:

Year:  2006        PMID: 16849398      PMCID: PMC2632278          DOI: 10.1093/schbul/sbl009

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  51 in total

1.  Social patterns of substance use among people with dual diagnoses.

Authors:  H Alverson; M Alverson; R E Drake
Journal:  Ment Health Serv Res       Date:  2001-03

2.  Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.

Authors:  W Katon; M Von Korff; E Lin; G Simon; E Walker; J Unützer; T Bush; J Russo; E Ludman
Journal:  Arch Gen Psychiatry       Date:  1999-12

3.  Clinically significant change: Jacobson and Truax (1991) revisited.

Authors:  D C Speer
Journal:  J Consult Clin Psychol       Date:  1992-06

4.  Improving primary care for depression in late life: the design of a multicenter randomized trial.

Authors:  J Unützer; W Katon; J W Williams; C M Callahan; L Harpole; E M Hunkeler; M Hoffing; P Arean; M T Hegel; M Schoenbaum; S M Oishi; C A Langston
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

5.  Strengthening clinical effectiveness trials: equipoise-stratified randomization.

Authors:  P W Lavori; A J Rush; S R Wisniewski; J Alpert; M Fava; D J Kupfer; A Nierenberg; F M Quitkin; H A Sackeim; M E Thase; M Trivedi
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

6.  Family support and substance use outcomes for persons with mental illness and substance use disorders.

Authors:  R E Clark
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

7.  The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.

Authors:  R E Drake; H Xie; G J McHugo; A I Green
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

8.  An ethnographic study of the longitudinal course of substance abuse among people with severe mental illness.

Authors:  H Alverson; M Alverson; R E Drake
Journal:  Community Ment Health J       Date:  2000-12

9.  Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness.

Authors:  M S Swartz; J W Swanson; H R Wagner; B J Burns; V A Hiday
Journal:  J Nerv Ment Dis       Date:  2001-09       Impact factor: 2.254

10.  Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

Authors:  H R Kranzler; J Van Kirk
Journal:  Alcohol Clin Exp Res       Date:  2001-09       Impact factor: 3.455

View more
  9 in total

1.  Management of persons with co-occurring severe mental illness and substance use disorder: program implications.

Authors:  Robert E Drake; Kim T Mueser; Mary F Brunette
Journal:  World Psychiatry       Date:  2007-10       Impact factor: 49.548

2.  Substance use outcomes among homeless clients with serious mental illness: comparing Housing First with Treatment First programs.

Authors:  Deborah K Padgett; Victoria Stanhope; Ben F Henwood; Ana Stefancic
Journal:  Community Ment Health J       Date:  2010-01-09

3.  Developing and testing adaptive treatment strategies using substance-induced psychosis as an example.

Authors:  Ree Dawson; Alan I Green; Robert E Drake; Thomas H McGlashan; Bella Schanzer; Philip W Lavori
Journal:  Psychopharmacol Bull       Date:  2008

4.  The influence of legal coercion on dropout from substance abuse treatment: results from a national survey.

Authors:  Brian E Perron; Charlotte L Bright
Journal:  Drug Alcohol Depend       Date:  2007-09-14       Impact factor: 4.492

5.  Dually diagnosed patients' responses to substance use disorder treatment.

Authors:  M Tyler Boden; Rudolf Moos
Journal:  J Subst Abuse Treat       Date:  2009-06-21

6.  Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study.

Authors:  César Pereiro; Carlos Pino; Gerardo Flórez; Manuel Arrojo; Elisardo Becoña
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

7.  Professionals' perception on the management of patients with dual disorders.

Authors:  Carlos Roncero; Néstor Szerman; Antonio Terán; Carlos Pino; José María Vázquez; Elena Velasco; Marta García-Dorado; Miguel Casas
Journal:  Patient Prefer Adherence       Date:  2016-09-19       Impact factor: 2.711

8.  The effects of residential dual diagnosis treatment on alcohol abuse.

Authors:  Stephen J Schoenthaler; Kenneth Blum; Lyle Fried; Marlene Oscar-Berman; John Giordano; Edward J Modestino; Rajendra Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2017-07-17

9.  A descriptive study of treatment provision for problem alcohol drinking in adult males in Khayelitsha, Cape Town, South Africa.

Authors:  Amina Saban; Neo Morojele; Leslie London
Journal:  BMC Health Serv Res       Date:  2017-12-04       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.